{
    "Trade/Device Name(s)": [
        "Xpert SA Nasal Complete"
    ],
    "Submitter Information": "Cepheid",
    "510(k) Number": "K243070",
    "Predicate Device Reference 510(k) Number(s)": [
        "K100822"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NQX",
        "OOI"
    ],
    "Summary Letter Date": "October 25, 2024",
    "Summary Letter Received Date": "September 27, 2024",
    "Submission Date": "September 27, 2024",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test Powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Staphylococcus aureus (SA)",
        "Methicillin-resistant Staphylococcus aureus (MRSA)",
        "staphylococcal protein A (spa)",
        "methicillin/oxacillin resistance gene (mecA)",
        "staphylococcal cassette chromosome (SCCmec)"
    ],
    "Specimen Type(s)": [
        "Nasal swab"
    ],
    "Specimen Container(s)": [
        "Double swab",
        "Elution reagent tube"
    ],
    "Instrument(s)/Platform(s)": [
        "GeneXpert Dx Systems",
        "GeneXpert System with Touchscreen",
        "GeneXpert Infinity-48s",
        "GeneXpert Infinity-80"
    ],
    "Method(s)/Technology(ies)": [
        "Automated real-time PCR",
        "Multiplex polymerase chain reaction",
        "Fluorogenic hybridization"
    ],
    "Methodologies": [
        "Nucleic acid amplification",
        "Real-time PCR",
        "Multiplex PCR"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Cartridge",
        "Reagent",
        "System",
        "Instrument"
    ],
    "Document Summary": "FDA 510(k) summary for Cepheid Xpert SA Nasal Complete automated real-time PCR test for detection of MRSA and SA from nasal swabs using GeneXpert Instrument Systems",
    "Indications for Use Summary": "Qualitative in vitro diagnostic test for detection of SA and MRSA from nasal swabs to aid in prevention and control of MRSA/SA infections in healthcare settings; not intended for diagnosis or treatment guidance; negative result does not preclude colonization; concomitant cultures needed for epidemiological typing or further susceptibility testing.",
    "fda_folder": "Microbiology"
}